Indivior PLC (INDV) reinvents leadership and moves list to Nasdaq
Recently I’ve put together a list 10 best midcap stocks to buy according to the billionaire. Indivior PLC ranks seventh on our list among the best midcap stocks, according to the billionaire.
Indivior PLC (NASDAQ:INDV) is a pharmaceutical company focused on opioid addiction treatment, particularly through its flagship product sublacade, which is a monthly buprenorphine injection. The company has demonstrated strong growth and resilience, reaching its shares for 52 weeks.
In 2025, Indivior PLC (NASDAQ: INDV) underwent a strategic leadership overhaul to strengthen its market position in the US, a key area of its operations. Joe Ciaffoni took over as CEO, bringing a new vision for the company, while Patrick Barry, as Chief Commercial Officer, pushed for the expansion of commercial operations, especially around Sublocade. Tony Kingsley has also joined the board to strengthen governance. These changes reflect intensive efforts to boost performance and align leadership with US market priorities. In line with this strategy, the business has announced plans to shift its main list from the London Stock Exchange to NASDAQ, aiming to improve visibility and investor engagement in the American market.
Photo by Matteo Badini Above interpretation
Clinically, Indivior PLC (NASDAQ:INDV) presented new findings at the 2025 CPDD conference that showed that high buprenorphine exposure could improve outcomes in patients with high fentanyl use. This is an important step given the ongoing fentanyl crisis. The FDA also approved the updated labels for sublacades, further expanding its clinical utility.
Although we acknowledge the potential of INDV as an investment, we believe certain AI stocks offer greater promotion potential and pose a risk of decline. If you’re looking for a highly undervalued AI stock that can make a significant profit from the tariff and supervision trends of the Trump era, check out our free report. Best Short-Term AI Stocks.
Read next: Best and worst dowstock for the next 12 months and 10 unstoppable stocks that can double your money.
Disclosure: None.